ConductScience.org, home

Paper16140331

The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice.

Ko J and 4 others. J Surg Res, 2005. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice. Papers, record 16140331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16140331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice.
PubMed
Journal
J Surg Res
PubMed
Year
2005
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
0.8
iCite
Revised in PubMed
2022-03-25
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ko JJason
2Ross JJoel
3Awad HHani
4Hurwitz HHerbert
5Klitzman BBruce

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PiperidinesMajor topic
QuinazolinesMajor topic
SkinMajor topic
Vascular Endothelial Growth Factor Receptor-2Major topic
Wound HealingMajor topic
Wounds and InjuriesMajor topic
Animals
Body Weight
Dermatologic Surgical Procedures
Female
Mice
Mice, Inbred BALB C
Microcirculation
Neovascularization, Physiologic
Signal Transduction
Stress, Mechanical

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
5 K23 CA85582-03NCI NIH HHSUnited StatesK23CA855820PubMedNIH RePORTER
GM0679NIGMS NIH HHSUnited StatesK12GM000679PubMed and NIHNIH RePORTER
K23CA085582NIHNIH RePORTER

Download CSV of grants

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
40251464The Adverse Impact of Tyrosine Kinase Inhibitors on Wound Healing and Repair.Int Wound J2025https://conductscience.org/library/papers/40251464PubMed
38611066Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives.Cancers (Basel)2024https://conductscience.org/library/papers/38611066PubMed
33746571Identification of key genes and pathways in scleral extracellular matrix remodeling in glaucoma: Potential therapeutic agents discovered using bioinformatics analysis.Int J Med Sci2021https://conductscience.org/library/papers/33746571PubMed
30087804VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury.Adv Wound Care (New Rochelle)2018https://conductscience.org/library/papers/30087804PubMed
28631382A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy.Int J Cancer2017https://conductscience.org/library/papers/28631382PubMed
25602294Acute cutaneous wounds treated with human decellularised dermis show enhanced angiogenesis during healing.PLoS One2015https://conductscience.org/library/papers/25602294PubMed
24526268Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patients.Drug Saf2014https://conductscience.org/library/papers/24526268PubMed
22850548Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation.Br J Cancer2012https://conductscience.org/library/papers/22850548PubMed
22258296Perioperative polyphenon E- and siliphos-inhibited colorectal tumor growth and metastases without impairment of gastric or abdominal wound healing in mouse models.Surg Endosc2012https://conductscience.org/library/papers/22258296PubMed
20978113Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.Cancer Prev Res (Phila)2010https://conductscience.org/library/papers/20978113PubMed
19687425Cutaneous pigmentation after photosensitivity induced by vandetanib therapy.Arch Dermatol2009https://conductscience.org/library/papers/19687425PubMed
18427552Regulation of scar formation by vascular endothelial growth factor.Lab Invest2008https://conductscience.org/library/papers/18427552PubMed
18004538[Pathophysiology of wound healing and current treatment strategies in a urological context].Urologe A2007https://conductscience.org/library/papers/18004538PubMed
17519900Mechanisms of adverse effects of anti-VEGF therapy for cancer.Br J Cancer2007https://conductscience.org/library/papers/17519900PubMed
16763865[(Side) effects of VEGF inhibition].Ophthalmologe2006https://conductscience.org/library/papers/16763865PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
KDR3791PubTator's text mininghttps://conductscience.org/library/genes/3791

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16140331

GET https://conductscience.org/api/papers/v1/16140331/authors